AQP4 and neuromyelitis optica: However, one complication in using passive transfer is that acute intravenous injection of AQP4-IgG has difficulty producing neurology dysfunction or NMO pathology (54, 55), as AQP4-IgGs cannot pass through an undamaged BBB.